This inventor holds 1 USPTO granted patent. Top assignee: Biochem Therapeutics Incorporated. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Guy Falardeau: Innovator in Antiviral Compounds
Introduction
Guy Falardeau is a notable inventor based in Ste.-Dorothee, Canada. He has made significant contributions to the field of antiviral research, particularly in the development of compounds that inhibit cytomegalovirus (CMV). His work is crucial in the ongoing fight against viral infections in mammals.
Latest Patents
Falardeau holds a patent for "Cytomegalovirus inhibiting compounds." This invention relates to heterocyclic compounds that exhibit antiviral activity. Specifically, the compounds of formula (I) are designed to be effective in the therapy and prophylaxis of cytomegalovirus infection in mammals. He has 1 patent to his name, showcasing his innovative approach to combating viral diseases.
Career Highlights
Throughout his career, Falardeau has been associated with Biochem Therapeutics Incorporated, where he has focused on developing antiviral therapies. His expertise in the field has positioned him as a key player in the research and development of effective treatments for viral infections.
Collaborations
Some of his notable coworkers include Haolun Jin and Laval C Chan. Their collaborative efforts contribute to the advancement of research in antiviral compounds and therapies.
Conclusion
Guy Falardeau's work in developing cytomegalovirus inhibiting compounds highlights his commitment to advancing antiviral research. His contributions are vital in the ongoing battle against viral infections, making him a significant figure in the field of biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile